Black Rock Inc. Imara Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.73 - $5.2 $17,736 - $24,726	4,755 Added 4.33%	114,550 $468,000
Q3 2022 Nov 14, 2022	SELL	$1.11 - $2.42 $14,614 - $31,861	-13,166 Reduced 10.71%	109,795 $252,000
Q2 2022 Aug 12, 2022	BUY	$0.99 - $1.87 $15,409 - $29,106	15,565 Added 14.49%	122,961 $150,000
Q1 2022 May 12, 2022	BUY	$1.15 - $2.41 $4,141 - $8,678	3,601 Added 3.47%	107,396 $202,000
Q4 2021 Feb 10, 2022	BUY	$2.25 - $4.05 $1,575 - $2,835	700 Added 0.68%	103,795 $234,000
Q3 2021 Nov 09, 2021	BUY	$4.08 - $7.83 $103,717 - $199,046	25,421 Added 32.73%	103,095 $420,000
Q2 2021 Aug 11, 2021	BUY	$6.78 - $9.04 $526,629 - $702,172	77,674 New	77,674 $613,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.